The L-80 series chillers have been specially adapted for cooling isopropyl alcohol used in the quenching process of aluminum heat treatment. After extensive research and testing of various technologies, a leading aerospace manufacturer has chosen
"We are very pleased to witness the positive impact our L-80 series chillers are having on the aerospace manufacturing industry," said
The L-80 MAX and L-80 Lite chillers utilize patented liquid nitrogen cooling technology to rapidly reduce the temperature of isopropyl alcohol to -80°C with a precision of ±5°C in less than an hour. This capability accelerates the quenching process and allows for consistent and monitored bath temperatures, enhancing aerospace components' strength and durability.
The success of the L-80 series chillers in the aerospace industry has opened doors for potential adoption in other sectors.
For more information about Cryometrix chillers for cryo treatment and the groundbreaking L-80 series chillers, please visit https://tinyurl.com/2s43vnsf.
About
Forward-Looking Statements
This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Forward-looking statements are not a guarantee of future performance or results, and will not necessarily be accurate indications of the times at, or by, which such performance or results will be achieved. Forward-looking statements are based on information available at the time the statements are made and involve known and unknown risks, uncertainties and other factors that may cause our results, levels of activity, performance or achievements to be materially different from the information expressed or implied by the forward-looking statements in this press release. This press release should be considered in light of the disclosures contained in the filings of the Company that are contained in the
Contact Investor Relations 801-607-1039 investor_relations@reflectscientific.com
Source:
2024 GlobeNewswire, Inc., source